Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Dr. Lal Pathlabs Ltd. Share Price
Day's Range
Day's Range
Low
₹1,551.90
High
₹1,623.40
Price Summary
| Previous Close | ₹1,605.00 |
|---|---|
| Day's Range | ₹1,551.90 - ₹1,623.40 |
| Open | ₹1,558.00 |
| 52 Week Range | ₹1,272.60 - ₹1,770.00 |
| Volume | 3,18,504 |
| Market Cap | ₹0.03 |
| Previous Close | ₹1,607.90 |
|---|---|
| Day's Range | ₹1,537.40 - ₹1,622.20 |
| Open | ₹1,537.40 |
| 52 Week Range | ₹1,272.00 - ₹1,771.30 |
| Volume | 23,446 |
| Market Cap | ₹0.03 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 5,111.99 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 1.31 |
| Price/Earning (TTM) | 52.03 |
| TTM EPS (₹) | 30.11 |
| P/E Ratio | 42.52 |
| Book Value(₹) | 10.47 |
| PAT Margin (%) | 20.00 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 31.53 |
| Trade Value ( ₹ in Lacs) | 376.99 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 1.31 |
| Price/Earning (TTM) | 52.03 |
| TTM EPS (₹) | 30.11 |
| P/E Ratio | 42.52 |
| Book Value(₹) | 10.47 |
| PAT Margin (%) | 20.00 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 31.53 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5772.0 | 23516.0 |
| Expenses | N/A | N/A |
| PBT | 1449.0 | 6213.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1484.0 | 4973.0 |
About Dr. Lal Pathlabs Ltd.
| Founded | 1995 |
|---|---|
| NSE Symbol | LALPATHLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,134.01 | 1,850.85 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,77,883.86 | 6,690.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,47,526.68 | 4,370.40 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,12,696.26 | 8,039.80 | 6,677.50 - 6,677.50 |
| Lupin Ltd. | 1,12,463.67 | 2,398.20 | 1,836.80 - 1,836.80 |
| Cipla Ltd. | 1,10,088.66 | 1,348.90 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,09,072.97 | 1,294.80 | 1,138.50 - 1,138.50 |
| Max Healthcare Institute Ltd. | 98,793.98 | 1,015.25 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 98,063.24 | 2,450.25 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 94,596.06 | 942.70 | 835.50 - 835.50 |
No Records Found
Latest News
Dr. Lal PathLabs informs about update on acquisition
Dr. Lal PathLabs informs about analysts meet
Biocon informs about monitoring agency reports
Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, Biocon has informed that it enclosed the Monitoring Agency Reports dated May 07, 2026 issued by India Ratings & Research, Monitoring Agency, in respect of utilisation of proceeds raised through Qualified Institutions Placements by the Company, for the quarter ended March 31, 2026. The Audit Committee and Board of Directors of the Company have reviewed and took note of the Monitoring Agency Reports at their respective meetings held on May 07, 2026. The above-mentioned information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Thyrocare Tech. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 2106.70 | 1738.70 | 21.17 | 7742.70 | 6331.00 | 22.30 | 7742.70 | 6331.00 | 22.30 |
| Other Income | 37.20 | 45.40 | -18.06 | 133.90 | 133.40 | 0.37 | 133.90 | 133.40 | 0.37 |
| PBIDT | 763.50 | 601.80 | 26.87 | 2697.20 | 2003.60 | 34.62 | 2697.20 | 2003.60 | 34.62 |
| Interest | 14.30 | 6.00 | 138.33 | 21.80 | 26.30 | -17.11 | 21.80 | 26.30 | -17.11 |
| PBDT | 749.20 | 595.80 | 25.75 | 2615.70 | 1977.30 | 32.29 | 2615.70 | 1977.30 | 32.29 |
| Depreciation | 129.40 | 117.80 | 9.85 | 511.70 | 465.20 | 10.00 | 511.70 | 465.20 | 10.00 |
| PBT | 619.80 | 478.00 | 29.67 | 2104.00 | 1512.10 | 39.14 | 2104.00 | 1512.10 | 39.14 |
| TAX | 184.00 | 258.50 | -28.82 | 615.90 | 554.30 | 11.11 | 615.90 | 554.30 | 11.11 |
| Deferred Tax | 23.50 | 114.20 | -79.42 | 43.00 | 76.60 | -43.86 | 43.00 | 76.60 | -43.86 |
| PAT | 435.80 | 219.50 | 98.54 | 1488.10 | 957.80 | 55.37 | 1488.10 | 957.80 | 55.37 |
| Equity | 1591.70 | 529.90 | 200.38 | 1591.70 | 529.90 | 200.38 | 1591.70 | 529.90 | 200.38 |
| PBIDTM(%) | 36.24 | 34.61 | 4.71 | 34.84 | 31.65 | 10.07 | 34.84 | 31.65 | 10.07 |
Innova Captab - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 3582.77 | 2425.22 | 47.73 | 12988.14 | 9580.61 | 35.57 | 12988.14 | 9580.61 | 35.57 |
| Other Income | 26.80 | 43.56 | -38.48 | 132.43 | 167.75 | -21.06 | 132.43 | 167.75 | -21.06 |
| PBIDT | 413.19 | 325.36 | 26.99 | 1646.10 | 1390.74 | 18.36 | 1646.10 | 1390.74 | 18.36 |
| Interest | 39.81 | 18.69 | 113.00 | 154.21 | 21.68 | 611.30 | 154.21 | 21.68 | 611.30 |
| PBDT | 373.38 | 306.67 | 21.75 | 1491.89 | 1369.06 | 8.97 | 1491.89 | 1369.06 | 8.97 |
| Depreciation | 94.03 | 78.12 | 20.37 | 373.67 | 170.15 | 119.61 | 373.67 | 170.15 | 119.61 |
| PBT | 279.35 | 228.55 | 22.23 | 1118.22 | 1198.91 | -6.73 | 1118.22 | 1198.91 | -6.73 |
| TAX | 67.73 | 57.30 | 18.20 | 281.30 | 304.21 | -7.53 | 281.30 | 304.21 | -7.53 |
| Deferred Tax | 58.38 | 29.89 | 95.32 | 103.65 | 84.21 | 23.09 | 103.65 | 84.21 | 23.09 |
| PAT | 211.62 | 171.25 | 23.57 | 836.92 | 894.70 | -6.46 | 836.92 | 894.70 | -6.46 |
| Equity | 572.25 | 572.25 | 0.00 | 572.25 | 572.25 | 0.00 | 572.25 | 572.25 | 0.00 |
| PBIDTM(%) | 11.53 | 13.42 | -14.04 | 12.67 | 14.52 | -12.69 | 12.67 | 14.52 | -12.69 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Dr. Lal Pathlabs Ltd. is ₹1,605.00 as of 2026-05-08.
The market capitalisation of Dr. Lal Pathlabs Ltd. is ₹26,262.97 as of 2026-05-07.
The 1-year return of Dr. Lal Pathlabs Ltd. is 39.50% as of 2026-05-08.
The P/E ratio of Dr. Lal Pathlabs Ltd. is 42.52 as of 2026-05-08.
The 52-week high and low of Dr. Lal Pathlabs Ltd. are ₹1,770.00 and ₹1,272.60, respectively, as of 2026-05-08.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
